Phase 3Completed

Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Amlodipine Alone

A Multicenter Trial to Evaluate the Safety and Efficacy of the Combination of Valsartan/Amlodipine 160/10 mg Versus Amlodipine 10 mg Alone for 8 Weeks in Hypertensive Patients Who Are Not Adequately Controlled on Amlodipine 10 mg Monotherapy

Sponsor
Novartis (Industry)
Enrollment
936 enrolled
Conditions
Hypertension
Interventions
valsartan/amlodipine
Ages
adults, older adults
Registry
NCT00171002

Full record on ClinicalTrials.gov

From the registry

This study will test the effectiveness and safety of a combination treatment in patients whose blood pressure is not controlled with a single medication

Primary outcomes

  • Change from baseline in diastolic blood pressure after 8 weeks

History

  1. Last registry update

  2. Registered

  3. Primary completion

  4. Started